MNA ANALYSIS: Asia Makes Its Mark in November Deals
This article was originally published in Clinica
The 19 mergers and acquisitions appearing in Clinica’s M&A tracker for November include companies in a wide variety of industry niches, and the month’s biggest deals were from Asia.
You may also be interested in...
Early results from the Low-Risk Bicuspid study of the Evolut transcatheter aortic valve replacement system showed low rates of all-cause mortality or stroke.
The Onyx One Clear study, evaluating the Resolute Onyx drug-eluting stent in high bleeding risk patients, met its primary endpoint at the one-year follow up.
The US government’s Biomedical Advanced Research and Development Authority has awarded Nanomix up to $570,000 to develop a SARS-CoV-2 test for its portable, rapid Nanomix eLab analyzer.